Evolution of the Average Target: Coupang, Inc.

Evolution of the Target Price: Coupang, Inc.

Changes in Analyst Recommendations: Coupang, Inc.

e3b730ae02e85f79459675690db1.m_yzwasS4ohrHsBssu1yhlAj25MtPpbrbV1vPBQf-JM.qL3g8sZDls0TKYkL2ZQ69gJOnOloR_maHmRaW1V3rOf1q_-j8SeryiBLkQ~c8a677a28c1edd73b71cb73a13224f1d
03-02 Morgan Stanley Trims Price Target on Coupang to $29 From $31, Keeps Overweight Rating MT
03-02 Nomura Adjusts Coupang Price Target to $20 From $22, Maintains Neutral Rating MT
02-05 Bernstein Initiates Coverage on Coupang With Underperform Rating, $17 Price Target MT
01-16 Deutsche Bank Upgrades Coupang to Buy From Hold, Adjusts Price Target to $25 From $29 MT
01-13 Coupang Shares Fall After Nomura Downgrade MT
01-13 Nomura Downgrades Coupang to Neutral From Buy, Cuts Price Target to $22 From $30 MT
01-13 Nomura Downgrades Coupang to Neutral From Buy, Cuts Price Target to $22 From $30 MT
12-17 Nomura Adjusts Coupang Price Target to $30 From $38, Maintains Buy Rating MT
18/09/25 Arete Initiates Coverage on Coupang With Buy Rating, $40 Price Target MT
11/09/25 On the stock market, inflation pushes Oracle off the front page. Zonebourse
20/08/25 Coupang's Growing Taiwan Business to Drive Long-term Growth, Morgan Stanley Says MT
20/08/25 Morgan Stanley Lifts Price Target on Coupang to $35 From $32, Keeps Overweight Rating MT
06/08/25 Deutsche Bank Downgrades Coupang to Hold From Buy, Price Target is $27 MT
05/08/25 Coupang Q2 revenue up 16%, beats analyst expectations RE
27/05/25 Coupang to Meet 2025 Growth Targets as Market Share Gains Continue, Morgan Stanley Says MT
27/05/25 Morgan Stanley Raises Price Target on Coupang to $32 From $27, Keeps Overweight Rating MT
26/02/25 Deutsche Bank Upgrades Coupang to Buy From Hold MT
07/10/24 Bernstein Upgrades Coupang to Outperform From Underperform, Price Target is $30 MT
16/05/24 UBS Upgrades Coupang to Buy From Neutral MT
09/05/24 Barclays Adjusts Price Target on Coupang to $32 From $25, Maintains Overweight Rating MT
08/05/24 Mizuho Adjusts Coupang's Price Target to $23 From $20, Keeps Neutral Rating MT
16/04/24 Nomura Raises Price Target on Coupang to $26 From $21 on Increased Membership Fee, Keeps Buy Rating MT
15/04/24 Coupang Remains Top Pick Following Membership Fee Increase, Morgan Stanley Says MT
15/04/24 Citigroup Upgrades Coupang to Buy From Neutral, Adjusts Price Target to $26 From $19 MT
15/04/24 Morgan Stanley Lifts Price Target on Coupang to $26 From $24 to Reflect WOW Membership Price Increase; Overweight Kept MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+63.46%
+16.54%
+24.6%
+25.62%
+0.09%
+52.93%
+25.05%
+22.79%
- - - +29.26%
+43.9%
Average +30.42%
Weighted average by Cap. +17.26%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
16.59USD
Average target price
27.12USD
Spread / Average Target
+63.46%
High Price Target
36.00USD
Spread / Highest target
+117.00%
Low Price Target
15.00USD
Spread / Lowest Target
-9.58%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Morgan Stanley
Nomura
Bernstein
Deutsche Bank Securities
Arete
UBS
Barclays
Mizuho Securities
Citigroup
BofA Securities
New Street
Autonomous Research
HSBC
Macquarie
Credit Suisse
Goldman Sachs
Daiwa Securities
J.P. Morgan Chase
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
16.59USD
Average target price
27.12USD
Spread / Average Target
+63.46%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. CPNG Stock
  4. Consensus Coupang, Inc.